State budget has ‘positive steps’ but does not do enough for providers, residents, groups say
By
Lois A. Bowers
Jul 22, 2024
Senior living industry advocates in Pennsylvania say they are encouraged by steps to support older adults evident in the recently passed state budget, but they say much more needs to be done to support...
Enacted bill shows that dementia resources are ‘high priority,’ industry advocate says
By
Lois A. Bowers
Jul 23, 2024
A long-term care provider advocate in South Carolina says that recently passed legislation “makes it clear that improving resources and access to care for those with Alzheimer’s disease is a high priority”...
New laws increase public awareness, funding for dementia initiatives
By
Kimberly Bonvissuto
Jul 09, 2024
Increasing public awareness of Alzheimer’s and other forms of dementia, along with increasing services for people with diagnoses and their caregivers, are front and center in recent state initiatives...
Increasing RN staffing hours reduces injury-related ED visits by assisted living residents with dementia:...
By
Kimberly Bonvissuto
Jul 19, 2024
A new study found that increasing staffing hours of registered nurses in assisted living communities led to a 53% decrease in injury-related emergency department visits by residents living with Alzheimer’s...
State dementia oversight efforts must include representatives from entire long-term care continuum, experts...
By
Kimberly Bonvissuto
Jul 10, 2024
The potential creation of a permanent state division and advisory committee dedicated to Alzheimer’s disease and related disorders has won praise from Pennsylvania’s senior living industry advocates,...
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
FDA approves new drug to treat Alzheimer’s
Jul 02, 2024
In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
New framework for national plan on aging aims to ease access to LTSS for older adults
By
Kimberly Bonvissuto
May 31, 2024
Creating a more person-centered, accessible system of care to enable older adults to more easily connect with long-term services and supports is part of a strategic framework for a national plan on aging...
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.